Johnson & Johnson Innovation has added to its network with the launch of a new initiative in Europe that combines venture investment and company incubation. Called JLINX, it is intended to catalyze scientific innovation and successful company formation by offering start-ups flexible ways to grow and collaborate across the European life sciences ecosystem.
Located in a fully dedicated facility on the Johnson & Johnson/Janssen Pharmaceutica NV campus in Beerse, Belgium, JLINX...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?